EVO Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Mai 2024 @ 16:15):

Stats
Tagesvolumen	17 141.00
Durchschnittsvolumen	110 098
Marktkapitalisierung	1.89B
EPS	$-0.120 ( 2023-11-08 )
Nächstes Ertragsdatum	( $-0.100 ) 2024-06-10
Last Dividend	$0.0722 ( 2019-01-11 )
Next Dividend	$0 ( N/A )
P/E	-21.36
ATR14	$0.0100 (0.19%)

Insider Trading

Date	Person	Action	Amount	type
2018-10-22	Anderson Mark Monroe	Buy	100 000	Stock Option (right to buy)
2018-10-22	Anderson Mark Monroe	Buy	0
2018-08-13	Smith Scott Clifford	Buy	100 000	Stock Option (right to buy)
2018-08-13	Smith Scott Clifford	Buy	0
2018-08-13	Laffer Arthur B	Buy	100 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 13 transactions
Buy: 500 392 \| Sell: 1 057

Volumen Korrelation

Lang: 0.11 (neutral)

Kurz: -0.72 (moderate negative)

Signal:(44.963) Neutral

Eaton Vance Ohio Korrelation

10 Am meisten positiv korreliert
SOJD	0.872
RYB	0.869
WPM	0.869
NEU	0.869
KBH	0.867
SAP	0.851
GLDM	0.85
SGOL	0.85
OUNZ	0.849
BAR	0.849

10 Am meisten negativ korreliert
DZZ	-0.856
EQNR	-0.84
GLL	-0.836
DGZ	-0.835
EBF	-0.829
DBMF	-0.817
RPM	-0.814
PKO	-0.814
PCQ	-0.814
KMLM	-0.809

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Eaton Vance Ohio Korrelation - Währung/Rohstoff

0.71
( moderate )

0.22
( neutral )

0.00
( neutral )

-0.57
( weak negative )

-0.46
( neutral )

-0.70
( moderate negative )

Eaton Vance Ohio Finanzdaten

Annual	2023
Umsatz:	$781.43M
Bruttogewinn:	$175.05M (22.40 %)
EPS:	$-0.470

FY	2023
Umsatz:	$781.43M
Bruttogewinn:	$175.05M (22.40 %)
EPS:	$-0.470

FY	2022
Umsatz:	$751.45M
Bruttogewinn:	$174.07M (23.16 %)
EPS:	$-0.990

FY	2021
Umsatz:	$618.03M
Bruttogewinn:	$151.54M (24.52 %)
EPS:	$0.650

Financial Reports:

No articles found.

Eaton Vance Ohio Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Eaton Vance Ohio Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 3.29 - low (9.42%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$0.0561	2001-01-05
Last Dividend	$0.0722	2019-01-11
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	221	--
Total Paid Out	$14.33	--
Avg. Dividend % Per Year	0.00%	--
Score	3.48	--
Div. Sustainability Score	3.29
Div.Growth Potential Score	0
Div. Directional Score	1.590	--

Next Divdend (Est)
(2024-06-25)

$0 Estimate 0.00 %

Dividend Stability

0.16 Bad

Dividend Score

3.48

Pay Frequency

Monthly

Yearly Payout

Year	Amount	Yield
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$1.008	24.50%
2005	$1.024	55.70%
2006	$0.704	34.50%
2007	$0.650	153.20%
2008	$0.738	177.80%
2009	$0.814	150.70%
2010	$0.966	61.90%
2011	$0.857	41.40%
2012	$0.832	54.40%
2013	$0.793	45.30%
2014	$0.732	28.90%
2015	$0.732	32.70%
2016	$0.570	25.20%
2017	$0.576	14.20%
2018	$0.495	6.05%
2019	$0.0722	0.71%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
ZTR	Dividend King	2024-02-09	Monthly	37	8.35%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.111	1.500	-2.22	-3.33	[0 - 0.5]
returnOnAssetsTTM	-0.0367	1.200	-1.224	-1.469	[0 - 0.3]
returnOnEquityTTM	-0.0731	1.500	-1.923	-2.88	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.944	0.800	5.28	4.22	[1 - 3]
quickRatioTTM	1.740	0.800	4.47	3.58	[0.8 - 2.5]
cashRatioTTM	1.100	1.500	5.00	7.50	[0.2 - 2]
debtRatioTTM	0.272	-1.500	5.46	-8.19	[0 - 0.6]
interestCoverageTTM	-6.79	1.000	-3.63	-3.63	[3 - 30]
operatingCashFlowPerShareTTM	0.192	2.00	9.94	10.00	[0 - 30]
freeCashFlowPerShareTTM	-1.029	2.00	-0.514	-1.029	[0 - 20]
debtEquityRatioTTM	0.559	-1.500	7.76	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.226	1.000	9.57	9.57	[0.2 - 0.8]
operatingProfitMarginTTM	-0.0826	1.000	-3.65	-3.65	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0542	1.000	-0.810	-0.810	[0.2 - 2]
assetTurnoverTTM	0.330	0.800	-1.130	-0.904	[0.5 - 2]
Total Score				3.29

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-10.48	1.000	-1.160	0	[1 - 100]
returnOnEquityTTM	-0.0731	2.50	-1.236	-2.88	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.029	2.00	-0.343	-1.029	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.192	2.00	9.94	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0263	1.500	-3.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0447	1.000	-1.383	0	[0.1 - 0.5]
Total Score				-0.106

Eaton Vance Ohio

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.